首頁 > 市場調查報告書 > 製藥

製藥企業製藥企業資料製藥企業策略

市場調查報告書

商品編碼

1750885

腫瘤學人工智慧市場規模、佔有率、趨勢分析報告：按組件類型、癌症類型、應用、最終用途、地區、細分市場預測，2025-2030 年

AI In Oncology Market Size, Share & Trends Analysis Report By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: 2025年05月05日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

腫瘤學人工智慧市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球腫瘤學人工智慧市場規模預計到2030年將達到191.7億美元，2025年至2030年期間的複合年成長率為26.17%。

由於全球人口中癌症盛行率的不斷上升，預計市場將出現顯著成長，這將推動開發用於診斷、治療和分析癌症的先進技術產品的需求。例如，國際癌症研究機構 (IARC) 預測，2023 年將新增超過 2,070 萬例新患者。此外，人工智慧對於實現早期發現和降低死亡率至關重要，尤其是透過高效的篩檢計畫。

由於生活方式改變和人口老化等多種因素，新興市場的癌症發生率正在上升。這些市場癌症患者的快速成長催生了對腫瘤人工智慧等先進技術的需求，這些技術旨在改善早期發現、個人化治療和患者的整體預後。例如，2024年1月，印度首個人工智慧精準腫瘤中心（POC）在班加羅爾阿波羅癌症中心開幕。該POC將充分利用人工智慧的巨大潛力，幫助腫瘤學家、患者和看護者在規定的時間內取得最佳療效。

人工智慧正在透過將多組體學分析的大量資料集與深度學習和高效能運算技術的最新進展相結合，改變腫瘤學領域。人工智慧的應用範圍正在擴展至新型檢測、篩檢、診斷和分類方法，癌症基因組學表徵，腫瘤微環境分析，預後和預測性生物標記評估，以及後續觀察和藥物研發策略等。例如，2022年10月，Model Medicines啟動了一項腫瘤學項目，專注於識別和開發針對兩個表觀遺傳和致癌性靶點的療法，並重點關注固態和骨髓惡性腫瘤的應用。

市場上的主要企業正致力於開發有助於早期癌症診斷的新產品，滿足日益成長的需求，並加強其開發平臺，採取合作夥伴關係和協作等策略。例如，2022年12月，Astra Zeneca與CliniThink合作推出了一個針對肺癌的人工智慧計劃。該計劃旨在早期發現肺癌並幫助開發有效的治療方法。

此外，2022年11月，Google健康與iCAD夥伴關係，利用該公司的人工智慧技術改善乳癌篩檢。此外，許多公共和私人組織正致力於資助和投資基於人工智慧的腫瘤篩檢產品的研發。例如，2023年3月，Artera獲得了9000萬美元的資金，用於推出和銷售ArteraAI前列腺檢測，這是第一個為預測局部性前列腺癌治療效果而開發的檢測。

腫瘤學人工智慧市場報告重點

根據組件類型，預計軟體解決方案部分在預測期內將以最快的複合年成長率成長。
根據癌症類型，由於前列腺癌在人群中的發生率不斷上升，預計預測期內其複合年成長率將最高。根據美國疾病管制與預防中心 (CDC) 發布的數據顯示，美國每 100 名男性中，就有 13 名患有攝護腺癌。
從應用角度來看，由於製藥公司廣泛採用和整合先進的人工智慧演算法，預計預測期內研發部門將以良好的複合年成長率成長。
根據最終用途，醫院佔據了市場主導地位，成長速度最快，這歸因於越來越多的公司與醫院合作或在醫院實施人工智慧癌症護理解決方案。
由於政府的有利舉措和數位基礎設施為患者提供數位解決方案，北美佔據了市場主導地位。

定義和範圍
2024 年及 2030 年區域市場佔有率分析
區域市場儀表板
區域市場概況
SWOT分析
北美洲
- 2018-2030年北美市場
- 美國
- 加拿大
歐洲
- 2018-2030年歐洲市場
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 丹麥
- 瑞典
- 挪威
亞太地區
- 2018-2030年亞太市場
- 日本
- 中國
- 印度
- 韓國
- 澳洲
- 泰國
拉丁美洲
- 2018-2030年拉丁美洲市場
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- MEA市場，2018-2030
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 科威特

9. 腫瘤學人工智慧市場競爭分析

主要市場參與企業的近期趨勢和影響分析
公司分類
公司簡介
- Azra AI
- IBM
- Siemens Healthcare GmbH
- Intel Corporation
- GE HealthCare
- NVIDIA Corporation
- Digital Diagnostics Inc.
- ConcertAI
- Median Technologies
- PathAI
- MVision AI

簡介目錄圖表

Product Code: GVR-4-68039-985-7

AI In Oncology Market Growth & Trends:

The global AI in oncology market size is estimated to reach USD 19.17 billion by 2030, expanding at a CAGR of 26.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically advanced products to diagnose, treat, and analyze cancer. For instance, the International Agency for Research on Cancer (IARC) expects over 20.7 million new cases in 2023. Moreover, AI enables early detection, crucial for lowering mortality, especially through efficient screening programs.

Emerging markets are witnessing a rising prevalence of cancer due to various factors, including lifestyle changes & aging populations. The surge in cancer cases in these markets creates a demand for advanced technologies like AI in oncology to improve early detection, personalized treatment, and overall patient outcomes. For instance, in January 2024, India's first AI-Precision Oncology Centre (POC) was launched at Apollo Cancer Centre in Bengaluru. The POC will utilize the vast possibilities offered by AI to help oncologists, patients, and caregivers achieve the best possible results within a specified time frame.

AI is transforming the field of oncology by integrating vast datasets from multi-omics analyses with the latest developments in deep learning and high-performance computing techniques. AI applications are expanding to include new detection, screening, diagnosis, and classification approaches, cancer genomics characterization, tumor microenvironment analysis, prognostic and predictive biomarkers assessment, and strategies for follow-up and drug discovery. For instance, in October 2022, Model Medicines launched an oncology program focusing on identifying and developing therapeutics against two epigenetic and oncogenic targets, focusing on applications for solid and hematological malignancies.

The major players operating in the market are adopting strategies such as collaborations and partnerships with a major focus on development of newer products to aid in the early diagnosis of cancer, meet rising demand, and enhance research and development pipeline. For instance, in December 2022, AstraZeneca collaborated with Clinithink to launch an AI project for lung cancer. This project aims to detect lung cancer at an early stage to aid in the developing of effective treatment.

Furthermore, in November 2022, Google Health entered into a partnership with iCAD, Inc. for the improvement of breast cancer screening using the company's artificial intelligence technology. Additionally, a number of public and private organizations are focusing on funding and investment for R&D in AI-based oncology screening products. For instance, in March 2023, Artera received funding of USD 90 million for the launch and distribution of the ArteraAI Prostate Test, the first developed test for predicting therapy in localized prostate cancer.

AI In Oncology Market Report Highlights:

Based on component type, the software solutions segment is anticipated to grow at the fastest CAGR over the forecast period, owing to increasing adoption of software solutions for a wide number of applications due to the better outcomes offered by this component
Based on cancer type, the prostate cancer segment is anticipated to grow at the fastest CAGR over the forecast period in the market with rising prevalence amongst the population. Prostate cancer generally affects 13 out of every 100 men in the U.S., according to the data published by CDC
Based on application type, the research and development segment is expected to grow at the lucrative CAGR over the forecast period. This is attributable to the widespread adoption and amalgamation of advanced AI-enabled algorithms in pharmaceutical companies
Based on end-use, the hospitals dominated the market and registered the fastest growth owing to growing number of companies collaborating or introducing AI-powered cancer care solutions in hospitals
North America dominated the market due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

Chapter 1 Methodology and Scope

1.1 Market Segmentation and Scope
- 1.1.1 Segment scope
- 1.1.2 Regional scope
- 1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
- 1.3.1 Purchased database
- 1.3.2 GVR's internal database
- 1.3.3 Secondary sources
- 1.3.4 Primary research
- 1.3.5 Details of primary research
1.4 Information or Data Analysis
- 1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
- 1.6.1 Commodity Flow Analysis
  - 1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations

Chapter 2 Executive Summary

2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 AI In Oncology Market Variables, Trends, & Scope

3.1 Market Lineage Outlook
- 3.1.1 Parent market analysis
3.2 Market Dynamics
- 3.2.1 Market drivers analysis
- 3.2.2 Market restraint analysis
- 3.2.3 Market opportunity analysis
- 3.2.4 Market challenges analysis
3.3 AI In Oncology: Market Analysis Tools
- 3.3.1 Industry analysis - Porter's
- 3.3.2 PESTLE analysis
3.4 Regulatory Framework
3.5 Case studies

Chapter 4 AI In Oncology Market Segment Analysis, By Component, 2018 - 2030 (USD Million)

4.1 Definition and Scope
4.2 Component Type Market Share Analysis, 2024 & 2030
4.3 Segment Dashboard
4.4 Global AI In Oncology Market, by Component, 2018 to 2030
4.5 Software Solutions
- 4.5.1 Software solutions market estimates and forecast, 2018 - 2030 (USD Million)
4.6 Hardware
- 4.6.1 Hardware market estimates and forecast, 2018 - 2030 (USD Million)
4.7 Services
- 4.7.1 Services market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 AI In Oncology Market Segment Analysis, By Cancer Type, 2018 - 2030 (USD Million)

5.1 Definition and Scope
5.2 Cancer Type Market Share Analysis, 2024 & 2030
5.3 Segment Dashboard
5.4 Global AI In Oncology Market, by Cancer Type, 2018 to 2030
5.5 Breast Cancer
- 5.5.1 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
5.6 Lung Cancer
- 5.6.1 Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
5.7 Prostate Cancer
- 5.7.1 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
5.8 Colorectal Cancer
- 5.8.1 Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
5.9 Brain Tumor
- 5.9.1 Brain tumor market estimates and forecast, 2018 - 2030 (USD Million)
5.10 Others
- 5.10.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 AI In Oncology Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

6.1 Definition and Scope
6.2 Application Market Share Analysis, 2024 & 2030
6.3 Segment Dashboard
6.4 Global AI In Oncology Market, by Application, 2018 to 2030
6.5 Diagnostics (Pathology, Cancer Radiology)
- 6.5.1 Diagnostics (pathology, cancer radiology) market estimates and forecast, 2018 - 2030 (USD Million)
6.6 Radiation Therapy (Radiotherapy)
- 6.6.1 Radiation therapy (radiotherapy) market estimates and forecast, 2018 - 2030 (USD Million)
6.7 Research & Development (Drug Design, Development Process, etc.)
- 6.7.1 Research & development (drug design, development process, etc.) market estimates and forecast, 2018 - 2030 (USD Million)
6.8 Chemotherapy
- 6.8.1 Chemotherapy market estimates and forecast, 2018 - 2030 (USD Million)
6.9 Immunotherapy
- 6.8.1 Immunotherapy market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 AI In Oncology Market Segment Analysis, By End Use Type, 2018 - 2030 (USD Million)

7.1 Definition and Scope
7.2 Application Market Share Analysis, 2024 & 2030
7.3 Segment Dashboard
7.4 Global AI In Oncology Market, by Application, 2018 to 2030
7.5 Hospitals
- 7.5.1 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.6 Surgical Centers & Medical Institutes
- 7.6.1 Surgical centers & medical institutes market estimates and forecast, 2018 - 2030 (USD Million)
7.7 Others (Pharmaceutical Companies, Research Institutes & Training Centers)
- 7.7.1 Others (pharmaceutical companies, research institutes & training centers) market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. AI In Oncology Market Segment Analysis, By Region, By Component, By Cancer Type, By Application, By End-use, 2018 - 2030 (USD Million)

8.1. Definition & Scope
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Regional Market Dashboard
8.4. Regional Market Snapshot
8.5. SWOT Analysis
8.6. North America
- 8.6.1. North America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.6.2. U.S.
  - 8.6.2.1. Key Country Dynamic
  - 8.6.2.2. Regulatory Framework
  - 8.6.2.3. Competitive Insights
  - 8.6.2.4. U.S. Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.6.3. Canada
  - 8.6.3.1. Key Country Dynamic
  - 8.6.3.2. Regulatory Framework
  - 8.6.3.3. Competitive Insights
  - 8.6.3.4. Canada Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7. Europe
- 8.7.1. Europe Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.7.2. Germany
  - 8.7.2.1. Key Country Dynamic
  - 8.7.2.2. Regulatory Framework
  - 8.7.2.3. Competitive Insights
  - 8.7.2.4. Germany Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.7.3. UK
  - 8.7.3.1. Key Country Dynamic
  - 8.7.3.2. Regulatory Framework
  - 8.7.3.3. Competitive Insights
  - 8.7.3.4. UK Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.7.4. France
  - 8.7.4.1. Key Country Dynamic
  - 8.7.4.2. Regulatory Framework
  - 8.7.4.3. Competitive Insights
  - 8.7.4.4. France Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.7.5. Italy
  - 8.7.5.1. Key Country Dynamic
  - 8.7.5.2. Regulatory Framework
  - 8.7.5.3. Competitive Insights
  - 8.7.5.4. Italy Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.7.6. Spain
  - 8.7.6.1. Key Country Dynamic
  - 8.7.6.2. Regulatory Framework
  - 8.7.6.3. Competitive Insights
  - 8.7.6.4. Spain Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.7.7. Denmark
  - 8.7.7.1. Key Country Dynamic
  - 8.7.7.2. Regulatory Framework
  - 8.7.7.3. Competitive Insights
  - 8.7.7.4. Denmark Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.7.8. Sweden
  - 8.7.8.1. Key Country Dynamic
  - 8.7.8.2. Regulatory Framework
  - 8.7.8.3. Competitive Insights
  - 8.7.8.4. Sweden Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.7.9. Norway
  - 8.7.9.1. Key Country Dynamic
  - 8.7.9.2. Regulatory Framework
  - 8.7.9.3. Competitive Insights
  - 8.7.9.4. Norway Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.8. Asia Pacific
- 8.8.1. Asia Pacific Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.8.2. Japan
  - 8.8.2.1. Key Country Dynamic
  - 8.8.2.2. Regulatory Framework
  - 8.8.2.3. Competitive Insights
  - 8.8.2.4. Japan Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.8.3. China
  - 8.8.3.1. Key Country Dynamic
  - 8.8.3.2. Regulatory Framework
  - 8.8.3.3. Competitive Insights
  - 8.8.3.4. China Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.8.4. India
  - 8.8.4.1. Key Country Dynamic
  - 8.8.4.2. Regulatory Framework
  - 8.8.4.3. Competitive Insights
  - 8.8.4.4. India Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.8.5. South Korea
  - 8.8.5.1. Key Country Dynamic
  - 8.8.5.2. Regulatory Framework
  - 8.8.5.3. Competitive Insights
  - 8.8.5.4. South Korea Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.8.6. Australia
  - 8.8.6.1. Key Country Dynamic
  - 8.8.6.2. Regulatory Framework
  - 8.8.6.3. Competitive Insights
  - 8.8.6.4. Australia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.8.7. Thailand
  - 8.8.7.1. Key Country Dynamic
  - 8.8.7.2. Regulatory Framework
  - 8.8.7.3. Competitive Insights
  - 8.8.7.4. Thailand Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.9. Latin America
- 8.9.1. Latin America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.9.2. Brazil
  - 8.9.2.1. Key Country Dynamic
  - 8.9.2.2. Regulatory Framework
  - 8.9.2.3. Competitive Insights
  - 8.9.2.4. Brazil Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.9.3. Mexico
  - 8.9.3.1. Key Country Dynamic
  - 8.9.3.2. Regulatory Framework
  - 8.9.3.3. Competitive Insights
  - 8.9.3.4. Mexico Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.9.4. Argentina
  - 8.9.4.1. Key Country Dynamic
  - 8.9.4.2. Regulatory Framework
  - 8.9.4.3. Competitive Insights
  - 8.9.4.4. Argentina Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.10. MEA
- 8.10.1. MEA Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.10.2. South Africa
  - 8.10.2.1. Key Country Dynamic
  - 8.10.2.2. Regulatory Framework
  - 8.10.2.3. Competitive Insights
  - 8.10.2.4. South Africa Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.10.3. Saudi Arabia
  - 8.10.3.1. Key Country Dynamic
  - 8.10.3.2. Regulatory Framework
  - 8.10.3.3. Competitive Insight
  - 8.10.3.4. Saudi Arabia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.10.4. UAE
  - 8.10.4.1. Key Country Dynamic
  - 8.10.4.2. Regulatory Framework
  - 8.10.4.3. Competitive Insights
  - 8.10.4.4. UAE Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
- 8.10.5. Kuwait
  - 8.10.5.1. Key Country Dynamic
  - 8.10.5.2. Regulatory Framework
  - 8.10.5.3. Competitive Insights
  - 8.10.5.4. Kuwait Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)

Chapter 9. AI In Oncology Market - Competitive Analysis

9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company Categorization
9.3. Company Profiles
- 9.3.1. Azra AI
  - 9.3.1.1. Overview
  - 9.3.1.2. Financial Performance
  - 9.3.1.3. Service Benchmarking
  - 9.3.1.4. Strategic Initiatives
- 9.3.2. IBM
  - 9.3.2.1. Overview
  - 9.3.2.2. Financial Performance
  - 9.3.2.3. Service Benchmarking
  - 9.3.2.4. Strategic Initiatives
- 9.3.3. Siemens Healthcare GmbH
  - 9.3.3.1. Overview
  - 9.3.3.2. Financial Performance
  - 9.3.3.3. Service Benchmarking
  - 9.3.3.4. Strategic Initiatives
- 9.3.4. Intel Corporation
  - 9.3.4.1. Overview
  - 9.3.4.2. Financial Performance
  - 9.3.4.3. Service Benchmarking
  - 9.3.4.4. Strategic Initiatives
- 9.3.5. GE HealthCare
  - 9.3.5.1. Overview
  - 9.3.5.2. Financial Performance
  - 9.3.5.3. Service Benchmarking
  - 9.3.5.4. Strategic Initiatives
- 9.3.6. NVIDIA Corporation
  - 9.3.6.1. Overview
  - 9.3.6.2. Financial Performance
  - 9.3.6.3. Service Benchmarking
  - 9.3.6.4. Strategic Initiatives
- 9.3.7. Digital Diagnostics Inc.
  - 9.3.7.1. Overview
  - 9.3.7.2. Financial Performance
  - 9.3.7.3. Service Benchmarking
  - 9.3.7.4. Strategic Initiatives
- 9.3.8. ConcertAI
  - 9.3.8.1. Overview
  - 9.3.8.2. Financial Performance
  - 9.3.8.3. Service Benchmarking
  - 9.3.8.4. Strategic Initiatives
- 9.3.9. Median Technologies
  - 9.3.9.1. Overview
  - 9.3.9.2. Financial Performance
  - 9.3.9.3. Service Benchmarking
  - 9.3.9.4. Strategic Initiatives
- 9.3.10. PathAI
  - 9.3.10.1. Overview
  - 9.3.10.2. Financial Performance
  - 9.3.10.3. Service Benchmarking
  - 9.3.10.4. Strategic Initiatives
- 9.3.11. MVision AI
  - 9.3.11.1. Overview
  - 9.3.11.2. Financial Performance
  - 9.3.11.3. Service Benchmarking
  - 9.3.11.4. Strategic Initiatives

簡介目錄圖表

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global ai in oncology market, by region, 2018 - 2030 (USD Million)
Table 4 Global ai in oncology market, by component, 2018 - 2030 (USD Million)
Table 5 Global ai in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 6 Global ai in oncology market, by application, 2018 - 2030 (USD Million)
Table 7 Global ai in oncology market, by end use, 2018 - 2030 (USD Million)
Table 8 North America AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 9 North America AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 10 North America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 11 North America AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 12 North America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 13 U.S. AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 14 U.S. AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 16 U.S. AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 18 Canada AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 19 Canada AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 20 Canada AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 21 Europe AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 22 Europe AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 23 Europe AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 24 Europe AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 25 Europe AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 26 Germany AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 27 Germany AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 28 Germany AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 29 Germany AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 30 UK AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 31 UK AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 32 UK AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 33 UK AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 34 France AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 35 France AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 36 France AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 37 France AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 38 Italy AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 39 Italy AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 40 Italy AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 41 Italy AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 42 Spain AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 43 Spain AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 44 Spain AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 45 Spain AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 46 Denmark AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 47 Denmark AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 48 Denmark AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 49 Denmark AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 50 Sweden AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 51 Sweden AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 52 Sweden AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 53 Sweden AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 54 Norway AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 55 Norway AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 56 Norway AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 57 Norway AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 58 Asia Pacific AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 59 Asia Pacific AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 60 Asia Pacific AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 61 Asia Pacific AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 62 Asia Pacific AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 63 China AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 64 China AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 65 China AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 66 China AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 67 Japan AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 68 Japan AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 69 Japan AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 70 Japan AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 71 India AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 72 India AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 73 India AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 74 India AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 75 South Korea AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 76 South Korea AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 77 South Korea AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 78 South Korea AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 79 Australia AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 80 Australia AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 81 Australia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 82 Australia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 83 Thailand AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 84 Thailand AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 85 Thailand AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 86 Thailand AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 87 Latin America AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 88 Latin America AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 89 Latin America AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 90 Latin America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 91 Latin America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 92 Brazil AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 93 Brazil AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 94 Brazil AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 95 Brazil AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 96 Mexico AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 97 Mexico AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 98 Mexico AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 99 Mexico AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 100 Argentina AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 101 Argentina AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 103 Argentina AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 104 MEA AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 105 MEA AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 106 MEA AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 107 MEA AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 108 MEA AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 109 South Africa AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 110 South Africa AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 112 South Africa AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 117 UAE AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 118 UAE AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 119 UAE AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 120 UAE AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 121 Kuwait AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 122 Kuwait AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 124 Kuwait AI in oncology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 AI in oncology market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Commodity flow analysis
Fig. 5 Parent market analysis
Fig. 6 AI in oncology Market snapshot
Fig. 7 AI in oncology Market segment snapshot
Fig. 8 AI in oncology Market segment snapshot
Fig. 9 AI in oncology Market competitive landscape snapshot
Fig. 10 Market research process
Fig. 11 Parent market outlook (USD Billion) (2024)
Fig. 12 AI in oncology market dynamics
Fig. 13 Areas of interest most likely to benefit from AI in the next 10 years
Fig. 14 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
Fig. 15 Comparison between AI-integrated healthcare and traditional healthcare
Fig. 16 Porter's Analysis
Fig. 17 PESTEL Analysis
Fig. 18 AI in oncology market, component outlook key takeaways (USD Million)
Fig. 19 AI in oncology market: Component movement analysis, 2024 & 2030 (USD Million)
Fig. 20 Software solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Hardware market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 AI in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
Fig. 24 AI in oncology market: Cancer type movement analysis, 2024 & 2030 (USD Million)
Fig. 25 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Brain tumor market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 AI in cancer diagnostics market, application outlook key takeaways (USD Million)
Fig. 32 AI in oncology market: Application movement analysis, 2024 & 2030 (USD Million)
Fig. 33 Diagnostics (pathology, cancer radiology) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Radiation therapy (Radiotherapy) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Research & development market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 AI in oncology market, end-use outlook key takeaways (USD Million)
Fig. 39 AI in oncology market: End-user movement analysis, 2024 & 2030 (USD Million)
Fig. 40 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Surgical centers and medical institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Regional marketplace: Key takeaways
Fig. 44 AI in Oncology market: Regional outlook, 2024 & 2030 (USD Million)
Fig. 45 AI in Oncology market: Regional outlook, 2024 & 2030 (USD Million)
Fig. 46 North America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 U.S. AI in oncology market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 49 U.S. AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Canada AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Europe AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 UK AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Germany AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Spain AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 France AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Italy AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 63 Key country dynamics
Fig. 64 Norway AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Denmark AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Sweden AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 70 Key country dynamics
Fig. 71 Japan AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 China AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 India AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 76 Key country dynamics
Fig. 77 Australia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 78 Key country dynamics
Fig. 79 South Korea AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 80 Key country dynamics
Fig. 81 Thailand AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Latin America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 83 Key country dynamics
Fig. 84 Brazil AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Mexico AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 87 Key country dynamics
Fig. 88 Argentina AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 89 MEA AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 South Africa AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Saudi Arabia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 UAE AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Kuwait AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key company categorization
Fig. 99 Heat map analysis